Panel Discussion: Changing the Face of Cell Therapies with In Vivo Gene Engineering

Time: 3:00 pm
day: Day 1 – Track A – Afternoon


  • Exploring the potential to develop a universal cell therapy without ex vivo isolation/expansion of T-cells
  • How can we improve safety, dosing and efficacy by using mRNA to create CAR-T cells in vivo?
  • Discussing how to control the pharmacokinetic properties of the cell product